Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sinovac Biotech Ltd.

http://www.sinovac.com/

Latest From Sinovac Biotech Ltd.

COVID-19 Windfalls Carry Pharma Into Stormy Times: Key Takeaways From Scrip 100 And Outlook 2023

The past couple of years have generated important growth for the pharma industry thanks to its drugs and vaccines for COVID-19. But with the IRA, high inflation, rising interest rates and chilly public markets, biopharma faces challenges this year. Here, we summarize key messages from In Vivo’s Outlook 2023.

Outlook 2023 Scrip 100

Pfizer Leads An Unusual Year For The Scrip 100

Pfizer catapulted back into the lead in the pharmaceutical rankings on the strength of COVID-19 revenues while BioNTech and Moderna both made the list for the first time.

Outlook 2023 Sales & Earnings

Pandemic Drives China Surge In Asia 100 Sales

Notable new entrants moved into the Asia 100 this year, with growth catalyzed by COVID-19 vaccines.

Outlook 2023 Companies

China Winds Down 'COVID Zero' But Vaccine Fatigue, Other Worries Linger

Three years since the first cluster of SARS-CoV-2 infections were reported in Wuhan, China has finally put the first nail in the coffin of its strict "COVID Zero" policies. But as Beijing begins to relax its most restrictive rules, citizens remain concerned about ballooning infections, while a low vaccination rate among seniors and vaccine fatigue appear to be dimming hopes of a quick revitalization of the hard-hit economy and bruised consumer confidence.

China Coronavirus COVID-19
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Other Names / Subsidiaries
    • Beijing Kexing Bioproducts
    • Sinovac Dalian Vaccine Technology Co., Ltd.
    • Sinovac (Cayman) Limited
UsernamePublicRestriction

Register